Enliven Therapeutics
ELVN
#5218
Rank
A$1.80 B
Marketcap
$38.31
Share price
5.84%
Change (1 day)
80.00%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of June 2024 : A$0.25 M

According to Enliven Therapeutics's latest financial reports the company's total debt is A$0.25 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$0.49 M3.59%
2022-12-31A$0.47 M117.06%
2021-12-31A$0.21 M60.48%
2020-12-31A$0.13 M